Homozygosity for the methylenetetrahydrofolate reductase (MTHFR) 677C>T mutation (MTHFR TT) has been linked to an increased risk for stroke, coronary artery disease, and migraine headaches. The authors analyzed the potential link between MTHFR 677C>T homozygosity and childhood stroke. A true association might facilitate screening, recurrence risk stratification, and treatment in patients with cerebrovascular disease. They performed a retrospective chart review of children tested for the MTHFR 677C>/T mutation; 533 patients underwent MTHFR testing, and 8% were homozygous for the MTHFR 677C>T mutation. There was no difference in the cohort compared with the prevalence in the general population. This suggests that the MTHFR 677 C>T polymorphism played a minimal role or no role in stroke risk. However, the data suggest that the MTHFR TT genotype may influence migraine susceptibility in children because there was a higher proportion of migraine patients (28.6%) with the MTHFR TT homozygous genotype.
Frosst P., Blom HJ, Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet . 1995;10:111-113.
2.
Prengler M., Sturt N., Krywawych S., et al. Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: a potential risk factor for hyperhomocysteinemia, CVD and stroke in childhood. Dev Med Child Neurol. 2001;43:220-225.
3.
Cardo E., Monros E., Colome C., et al. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia and vitamin status. J Child Neurol. 2000;15:295-298.
4.
Pezzini A., Del Zotto E., Archetti S., et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke. 2002;33:664-669.
5.
Kara I., Sazci A., Ergul E., et al. Association of the C677T and A1298C polymorphisms in the 677C>T methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res. 2003;111:84-90.
6.
Kowa H., Yasui K., Takeshima T., et al. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet. 2000;96:762-764.
7.
Harker LA, Ross R., Slichter SJ, et al. Homocysteine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genetics. J Clin Invest. 1976;58:731-741.
8.
Wall RT, Harlan JM, Harker LA, Striker GEHomocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res. 1980;18:113-121.
9.
Stamler JS, Osborne JA, Jaraki O., et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest . 1993;91: 308-318.
10.
Cooke JP, Tsao PSIs NO an endogenous antiatherogenic molecule? Arterioscler Thromb. 1994;14:653-655.
11.
Headache Classification Committee of the International Headache Society.Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl):S1-S96.
12.
Bernard PS, Lay MJ, Wittwer CTIntegrated amplification and detection of the C677T point mutation in the methylenetetrahydrofolate reductase gene by fluorescence resonance energy transfer and probe melting curves. Anal Biochem. 1998;255:101-107.
13.
Arruda VR, von Zuben PM, Chiaparini LC, et al. The mutation A1a677→Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost. 1997;77:818-821.
14.
Wald DS, Law M., Morris JKHomocysteine and cardiovascular disease: evidence on causality from a meta-analysis . BMJ. 2002;325:1-7.
15.
Homocysteine Studies Collaboration.Homocysteine and risk of ischemic heart disease and stroke. JAMA. 2002;288:2015-2020.
16.
Konrad C., Müller GA, Langer C., et al. Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol. 2004;251:1242-1248.
17.
Pezzini A., Del Zotto E., Padovani A.Hyperhomocysteinemia: a potential risk factor for cervical artery dissection following chiropractic manipulation of the cervical spine. J Neurol. 2002;249:1401-1403.
18.
Caso V., Cardaioli G., Gallai V., Parnetti L.Vertebral artery dissection and hyperhomocysteinemia: a case report. Cerebrovasc Dis. 2000;10(suppl 4):S9-S11.
19.
Gallai V., Caso V., Paciaroni M., et al. Mild hyperhomocysteinemia: a possible risk factor for cervical artery dissection. Stroke. 2001;32:714-718.
20.
Lea RA, Ovcaric M., Sundholm J., et al. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med. 2004;2:3.
21.
Oterino A., Valle N., Bravo Y., et al. MTHFR T677 homozygosis influences the presence of aura in migraineurs . Cephalalgia. 2004;24:491-494.
22.
Cupini LM, Stipa E.Migraine aura status and hyperhomocysteinemia. Cephalalgia . 2007;27:847-849.
23.
Di Rosa G.Efficacy of folic acid in children with migraine, hyperhomocysteinemia and MTHFR polymorphisms. Headache. 2007; 47:1342-1344.
24.
Signorello MG, Segantin A., Passalacqua M., Leoncini G.Homocysteine decreases platelet NO level via protein kinase activation. Nitric Oxide. 2009 ;20:104-113.
Pettigrew LC , Bang H., Chambless LE, et al. Vitamin Intervention for Stroke Prevention Investigators.Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial. Atherosclerosis. 2008;200:345-349.
